[1] Tan TY, Hsu LY, Alejandria MM et al. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region[J]. Med Mycol,2016,54(5):471-477.
[2] Chan JG, Duke CC, Ong HX, et al. A novel inhalable form of rifapentine[J]. J Pharm Sci, 2014, 103(5):1411-1421.
[3] 王玉连, 张璐璐, 秦玉璘,等. 利福喷丁对氟康唑体外抗耐药白念珠菌的增效作用[J]. 中国真菌学杂志, 2016, 11(3):156-159.
[4] Judith Berman. Morphogenesis and cell cycle progression in Candida albicans[J]. current opinion in microbiology, 2006, 9(6):595-601.
[5] Arioli V, Berti M, Carniti G, et al. Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative[J]. J Antibiot (Tokyo), 1981, 34(8):1026-1032.
[6] Bollen M. Cell cycle:It takes three to find the exit[J]. Nature, 2015, 517(7532):29.
[7] Cuddihy AR, O'Connell MJ. Cell-cycle responses to DNA damage in G2[J]. Int Rev Cytol, 2003, 222(4):99-140.
[8] Yan L, Xiong J, Lu H, et al. The role of Mms22p in DNA damage response in Candida albicans[J]. G3(Bethesda), 2015, 5(12):2567-2578.
[9] Li DD, Xu Y, Zhang DZ, et al. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans[J]. Antimicrob Agents Chemother,2013, 57(12):6016-6027.
[10] 吕霞琳, 张宏, 宋延君,等. 汉防己甲素及其联合氟康唑对白念珠菌细胞周期影响的初步研究[J]. 中国真菌学杂志, 2014, 9(4):215-217. |